Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric catalytic hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel asymmetric hydrogenation method enables high-purity dihydro-9-phenanthrene amine production with enhanced supply chain reliability and cost efficiency for pharmaceutical manufacturing.
Patent CN115872905A enables high-purity API intermediate production with TON=100,000, reducing manufacturing costs and supply chain lead time through green catalysis.
Solve supply chain challenges for (Z)-2-acetylaminocinnamic acid methyl ester with 68%+ yield, 99%+ purity, and no column chromatography. Industrial-scale production ready.
Discover how this novel asymmetric catalytic hydrogenation method enables high-yield, high-ee synthesis of chiral dihydro-9-phenanthrene amine for pharmaceutical applications.
Solve racemic drug limitations with 99% ee asymmetric synthesis. Reduce production costs & supply chain risks for topical antifungal manufacturing. Contact for custom synthesis solutions.